Nebulized bacitracin/colimycin: A treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study

Rhinology

Volumn 46, Issue 2, 2008, Pages 92-98

  Videler, W J M ^a   van Drunen, C M ^a   Reitsma, J B ^a   Fokkens, Wytske J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chronic rhinosinusitis; Local antibiotics; Nebulizer; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; COLISTIN; OFLOXACIN;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MICROBIOLOGY; MIDDLE AGED; NEBULIZER; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SINUSITIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACITRACIN; CHRONIC DISEASE; COLISTIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; OFLOXACIN; PILOT PROJECTS; RHINITIS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 44849135824     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Melen I. Chronic sinusitis: clinical and pathophysiological aspects. Acta Otolaryngol. Suppl 1994; 515: 45-48.
2. Gliklich RE, Metson R. Economic implications of chronic sinusitis. Otolaryngol Head Neck Surg. 1998; 118: 344-349.
3. Harvey RJ, Lund VJ. Biofilms and chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research. Rhinology. 2007; 45: 3-13.
4. Desrosiers MY. Effectiveness of topical antibiotics on staphylococcus aureus biofilm in vitro. Am J Rhinol. 2007; 21: 149-153.
5. Bendouah Z. Use of an in vitro assay for determination of biofilm-forming capacity of bacteria in chronic rhinosinusitis. Am J Rhinol. 2007; 20: 434-438.
6. Levine HL. Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope. 1990; 100: 79-84.
7. Senior BA, Kennedy DW, Tanabodee J, et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope. 1998; 108: 151-157.
8. Kerrebijn JD, Drost HE, Spoelstra HA, et al. If functional sinus surgery fails: a radical approach to sinus surgery. Otolaryngol Head Neck Surg. 1996; 114: 745-747.
9. Videler WJ, Wreesmann VB, van der Meulen FW, et al. Repetitive endoscopic sinus surgery failure: a role for radical surgery? Otolaryngol Head Neck Surg. 2006, 134: 586-591.
10. Benninger MS, Anon J, Mabry RL. The medical management of rhinosinusitis. Otolaryngol Head Neck Surg. 1997; 117: S41-S49.
11. Leonard DW, Bolger WE. Topical antibiotic therapy for recalcitrant sinusitis. Laryngoscope. 1999; 109: 668-670.
12. Kamijyo A, Matsuzaki Z, Kikushima K, et al. Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx. 2001; 28: 227-232.
13. Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002; 127: 558-568.
14. Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J. 2002; 81: 648-652.
15. Antunes MB, Feldman MD, Cohen NA, et al. Dose-dependent effects of topical tobramycin in an animal model of Pseudomonas sinusitis. Am J Rhinol. 2007; 21: 423-427.
16. Sykes DA, Wilson R, Chan KL, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet. 1986; 2: 359-360.
17. Kobayashi T, Baba S. Topical use of antibiotics for paranasal sinusitis. Rhinology. Suppl 1992; 14: 77-81.
18. Desrosiers MY, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg. 2001; 125: 265-269.
19. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Nasal Polyps 2007. Rhinology. 2007; 45; suppl. 20: 1-136.
20. Chapnick EK, Gradon JD, Kreiswirth B, et al. Comparative killing kinetics of methicillin-resistant Staphylococcus aurcus by bacitracin or mupirocin. Infect Control Hosp Epidemiol. 1996; 17: 178-180.
21. Bryan CS, Wilson RS, Meade P, et al. Topical antibiotic ointments for staphylococcal nasal carriers: survey of current practices and comparison of bacitracin and vancomycin ointments. Infect Control. 1980; 1: 153-156.
22. Goldstein EJ, Citron DM, Bendon L, et al. Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates. Arch Ophthalmol. 1987; 105: 991-994.
23. Komatsuzawa H, Suzuki J, Sugai M, et al. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1994; 33: 1155-1163.
24. Sieradzki K, Tomasz A. Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics. J Antimicrob Chemother. 1997; 39 Suppl A: 47-51.
25. Ling B, Berger-Bachi B. Increased overall antibiotic susceptibility in Staphylococcus aureus fem AB null mutants. Antimicrob Agents Chemother. 1998; 42: 936-938.
26. Chalker AF, Ingraham KA, Lunsford RD, et al. The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence. Microbiology. 2000; 146: 1547-1553.
27. Afset JE, Maeland JA. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus. Scand J Infect Dis. 2003; 35: 84-89.
28. Negley JE, Krause H, Pawar S, et al. RinoFlow nasal wash and sinus system as a mechanism to deliver medications to the paranasal sinuses: results of a radiolabeled pilot study. Ear Nose Throat J. 1999; 78: 550-554.
29. Wreesmann VB, Fokkens WJ, Knegt PP. Refractory chronic sinusitis: evaluation of symptom improvement after Denker's procedure. Otolaryngol Head Neck Surg. 2001; 125: 495-500.
30. Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol. 1998; 12: 233-241.
31. Klossek JM, Dubreuil L, Richet H, et al. Bacteriology of chronic purulent secretions in chronic rhinosinusitis. J Laryngol Otol. 1998; 112: 1162-1166.
32. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001; 107: 607-614.
33. Brook I, Frazier EH. Correlation between microbiology and previous sinus surgery in patients with chronic maxillary sinusitis. Ann Otol Rhinol Laryngol. 2001; 110: 148-151.
34. Araujo E, Palombini BC, Cantarelli V, et al. Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol. 2003; 17: 9-15.
35. Damm M, Quante G, Jurk T, et al. Nasal colonization with Staphylococcus aureus is not associated with the severity of symptoms or the extent of the disease in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2004; 131: 200-206.
36. Clement S, Vaudaux P, Francois P, et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis. 2005; 192: 1023-1028.
37. Plouin-Gaudon I, Clement S, Huggler E, et al. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology. 2006; 44: 249-254.
38. Bachert C, Gevaert P, van CP. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy. 2002; 57: 480-487.
39. Goh YH, Goode RL. Current status of topical nasal antimicrobial agents. Laryngoscope. 2000; 110: 875-880.
40. Elliott KA, Stringer SP. Evidence-based recommendations for antimicrobial nasal washes in chronic rhinosinusitis. Am J Rhinol. 2006; 20: 1-6.
41. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000; 110: 1189-1193.
42. Heatley DG, McConnell KE, Kille TL, et al. Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg. 2001; 125: 44-48.
43. Wormald PJ, Cain T, Oates L, et al. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004; 114: 2224-2227.
44. Olson DE, Rasgon BM, Hilsinger RL, Jr. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope. 2002; 112: 1394-1398.
45. Miller TR, Muntz HR, Gilbert ME, et al. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope. 2004; 114: 201-204.
46. Videler WJ, van Drunen CM, van der Meulen FW, et al. Radical surgery: effect on quality of life and pain in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2007; 136: 261-267.